Hypertension (HTN) is estimated to affect as much as 50% of the adult population in the United States or approximately 120 million people.1 It is further estimated that nearly 80% of these patients may remain suboptimally controlled, attributable to factors such as underrecognition, medication intolerance or cost, or undertreatment of secondary causes of HTN.2,3 Prior studies have projected that a decrease in the systolic blood pressure (SBP) by only 5 mm Hg translates into a 10% decrease in...